In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide

[1]  F. Schmidt.  Meta-Analysis , 2008 .

[2]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[3]  Charles R G Guttmann,et al.  Can MRI reveal phenotypes of multiple sclerosis? , 2006, Magnetic resonance imaging.

[4]  Ludwig Kappos,et al.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.

[5]  A. Darzi,et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet Oncology.

[6]  G. Bendas,et al.  Targeting of immunoliposomes to endothelial cells expressing VCAM: a future strategy in cancer therapy. , 2005, International journal of clinical pharmacology and therapeutics.

[7]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[8]  Simon K Warfield,et al.  Diffusion Tensor Magnetic Resonance Imaging in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  M. Reinhardt,et al.  Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ) , 2005, NeuroImage.

[10]  K. Leong,et al.  MR imaging of biodegradable polymeric microparticles: A potential method of monitoring local drug delivery , 2005, Magnetic resonance in medicine.

[11]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Atle Bjørnerud,et al.  Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging , 2004, Cell and Tissue Research.

[13]  A. Blamire,et al.  MRI detection of early endothelial activation in brain inflammation , 2004, Magnetic resonance in medicine.

[14]  Aliasger K Salem,et al.  Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Bodary,et al.  Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection , 2003, Expert opinion on biological therapy.

[16]  Eliana Gianolio,et al.  Insights into the use of paramagnetic Gd(III) complexes in MR‐molecular imaging investigations , 2002, Journal of magnetic resonance imaging : JMRI.

[17]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[18]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[19]  R Stollberger,et al.  A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[20]  L. Steinman,et al.  ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging , 2000, Journal of Neuroimmunology.

[21]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[22]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[23]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[24]  H. Friess,et al.  Over‐expression of ICAM‐1, VCAM‐1 and ELAM‐1 might influence tumor progression in colorectal cancer , 1998, International journal of cancer.

[25]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[26]  C. Orosz,et al.  Role of the endothelial adhesion molecule VCAM in murine cardiac allograft rejection. , 1992, Immunology letters.

[27]  T. Carlos,et al.  Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. , 1990, Blood.

[28]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[29]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.